Not everyone needs this dose, but its available if youre tolerating lower doses well and want to maximize weight loss
I dont want what I went through to get brushed over, he continued
STEP-1 Trial (Semaglutide 2.4 mg, N=1,961) The STEP-1 trial published in the New England Journal of Medicine reported that among participants receiving semaglutide 2.4 mg subcutaneously once weekly, nausea occurred in 44.2%, diarrhea in 29.7%, vomiting in 24.5%, and constipation in 24.1%, compared to 16.0%, 15.9%, 6.8%, and 11.1% with placebo, respectively [3]
According to the 5x half-life rule, the concentration of semaglutide in the blood is as follows: Clinical studies on semaglutide clearance In pharmacokinetic studies, semaglutides terminal half-life was measured at around 145 to 168 hours, or roughly seven days
Update 29, 395433